Additionally, the clinical colon cancer tissues and patient serum analysis were further supported that higher level of STC2 protein is present in colorectal tumor and patient's serum compared with normal samples, which also has linkage with tumor pathologic classification and CRC patient survival. This evidence concerns the gene STC2 and colorectal neoplasm.